APA (7th ed.) Citation

K, Y., K, H., T, K., H, M., K, I., S, O., & Y, M. (2025). Systolic blood pressure is associated with early and long-term changes in renal function in patients with dapagliflozin-treated moderate-to-advanced chronic kidney disease. Clinical and experimental nephrology, 29(9), 1200. https://doi.org/10.1007/s10157-025-02678-9

Chicago Style (17th ed.) Citation

K, Yanai, Hirai K, Kitano T, Miyazawa H, Ito K, Ookawara S, and Morishita Y. "Systolic Blood Pressure Is Associated with Early and Long-term Changes in Renal Function in Patients with Dapagliflozin-treated Moderate-to-advanced Chronic Kidney Disease." Clinical and Experimental Nephrology 29, no. 9 (2025): 1200. https://doi.org/10.1007/s10157-025-02678-9.

MLA (9th ed.) Citation

K, Yanai, et al. "Systolic Blood Pressure Is Associated with Early and Long-term Changes in Renal Function in Patients with Dapagliflozin-treated Moderate-to-advanced Chronic Kidney Disease." Clinical and Experimental Nephrology, vol. 29, no. 9, 2025, p. 1200, https://doi.org/10.1007/s10157-025-02678-9.